SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LTD.

Sharma East India Hospitals & Medical Research Ltd has announced the closure of its trading window for designated persons. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the announcement of the standalone unaudited financial results for the quarter ended June 30, 2026. The purpose of this closure is to facilitate the consideration of these financial results.

Sharma East India Hospitals & Medical Research Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the Standalone Audited Financial Results along with the Auditor's Report for the year ended March 31, 2026, pursuant to regulation 33 of SEBI (LODR) Regulation, 2015. The trading window for dealing in the company's securities has been closed from April 1, 2026, until 48 hours after the declaration of the financial results.

Sharma East India Hospitals & Medical Research Ltd. has announced the closure of its trading window for all designated persons. This closure is effective from Wednesday, April 1, 2026, and is in preparation for the consideration of the company's Standalone Audited Financial Results for the quarter and year ended March 31, 2026. The trading window will reopen 48 hours after the announcement of the financial results becomes generally available.

Sharma East India Hospitals & Medical Research Ltd announced the approval of its unaudited financial results for the quarter ended December 31, 2025. The company's revenue from operations for the quarter was Rs. 960.88 lakhs, representing a growth of approximately 17% compared to the same period last year. The total revenue for the quarter stood at Rs. 965.38 lakhs, while the total expenses amounted to Rs. 940.51 lakhs. As a result, the company reported a profit before tax of Rs. 24.87 lakhs and a net profit of Rs. 17.77 lakhs for the quarter. The earnings per share (EPS) for the quarter stood at Rs. 0.54.

Sharma East India Hospitals & Medical Research Ltd. announced the approval of their standalone un-audited financial results for the quarter ended December 31, 2025, in compliance with Regulation 33 of the Listing Obligation and Disclosure Requirement, 2015. The meeting was held on February 14, 2026, and the board approved the IND-AS compliant Standalone un-audited Financial Results. The company's revenue from operations for the quarter is Rs. 960.88 lakhs, with a profit before tax of Rs. 24.87 lakhs and a profit for the period of Rs. 17.77 lakhs.

Sharma East India Hospitals & Medical Research Ltd has announced that its Board of Directors will meet on February 14, 2026, to consider and approve the IND-AS compliant Standalone Un-audited Financial Results for the quarter ended on December 31, 2025. The meeting will also discuss any other business with the permission of the Chair and with the consent of a majority of the Directors present, including at least one Independent Director. The Trading Window for dealing in securities of the Company is closed from January 1, 2026, until 48 hours after the declaration of Un-audited financial results for the quarter ended on December 31, 2025.

Sharma East India Hospitals & Medical Research Ltd, scrip code 524548, has announced the closure of its trading window for all designated persons. The closure is effective from Thursday, 1st January 2026, and is in preparation for the consideration of Standalone un-audited Financial Results for the quarter and nine months ended December 31, 2025. The trading window will reopen 48 hours after the announcement of the results.

Sharma East India Hospitals & Medical Research Ltd announced the reconstitution of its Audit and Nomination and Remuneration Committees at the board meeting held on November 14, 2025. The Audit Committee will be chaired by Srikant Vinayakrao Bulakh, with Maya Sharma, Radhika Sathe, Dr Pushpendra Prasad Garg, and Pawan Shorey as members. The Nomination and Remuneration Committee will also be chaired by Srikant Vinayakrao Bulakh, with Maya Sharma, Radhika Sathe, Dr Pushpendra Prasad Garg, and Pawan Shorey as members.

Sharma East India Hospitals & Medical Research Ltd. announced the resignation of its Independent Non-Executive Director, Rajeev Kumar, due to pre-occupation and personal commitments. Kumar will cease to be a Chairman of the Audit Committee & Nomination and Remuneration Committee effective from close of business hours on November 14, 2025. The company has complied with the necessary regulations and has disclosed the information on its website.

Sharma East India Hospitals & Medical Research Ltd, a well-known healthcare provider, has announced its unaudited financial results for the quarter and half-year ended September 30, 2025. The company reported a revenue of Rs. 951.37 lakhs, with a net profit of Rs. 31.80 lakhs. The total assets stood at Rs. 3,147.04 lakhs, while total equity was at Rs. 1,311.25 lakhs as of September 30, 2025. The company's non-current assets amounted to Rs. 1,274.76 lakhs, and current assets stood at Rs. 1,872.28 lakhs.